The U.S. Patent and Trademark Office reopens the comment period on its proposed rulemaking and proposed examination guidelines, published on July 26, 2012, “to implement the first-inventor-to-file provisions of the Leahy-Smith America Invents Act.” Comments may now be submitted until November 5.

The U.S. Patent and Trademark Office launches a new Patent Prosecution Highway (PPH) with the Czech Republic’s patent office and plans to launch two additional PPHs with its counterparts in the Philippines and Portugal in January 2013. The office claims that the expedited examinations provided by its PPHs “will allow applicants to obtain corresponding patents faster and more efficiently” thus improving the international patent system.

The Presidential Commission for the Study of Bioethical Issues plans to convene its 11th meeting November 5-7, 2012, in Chicago, to “continue discussing topics related to the ethical issues associated with the development of medical countermeasures for children.” Written comments will be accepted at the registration desk, and the public is invited to participate. The meeting will be webcast at www.bioethics.gov.

The U.S. Food and Drug Administration’s (FDA’s) Risk Communication Advisory Committee is scheduled to meet November 2, 2012, to “discuss general factors in risk communication about FDA regulated products, including approaches to avoid message fatigue and related communication barriers such as prevention or warning fatigue or inaccurate risk perception.” Those wishing to speak must notify FDA by October 25, and written comments are due by that date.